IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell-mediated immunity.

Saved in:
Bibliographic Details
Title: IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell-mediated immunity.
Authors: Lim GY; College of Pharmacy and Natural Products Research Institute, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea., Ka NL; College of Pharmacy, Chonnam National University, Gwangju, 61186, Republic of Korea., Kim SS; College of Pharmacy and Natural Products Research Institute, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea., Lee MO; College of Pharmacy and Natural Products Research Institute, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea. molee@snu.ac.kr.; Bio-MAX institute, Seoul National University, Seoul, 08826, Republic of Korea. molee@snu.ac.kr.
Source: Breast cancer research : BCR [Breast Cancer Res] 2026 Jan 03; Vol. 28 (1), pp. 27. Date of Electronic Publication: 2026 Jan 03.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1465-542X
DOI:10.1186/s13058-025-02213-4